Secretome Screening Reveals Fibroblast Growth Factors as Novel Inhibitors of Viral Replication.
Ontology highlight
ABSTRACT: Cellular antiviral programs can efficiently inhibit viral infection. These programs are often initiated through signaling cascades induced by secreted proteins, such as type I interferons, interleukin-6 (IL-6), or tumor necrosis factor alpha (TNF-α). In the present study, we generated an arrayed library of 756 human secreted proteins to perform a secretome screen focused on the discovery of novel modulators of viral entry and/or replication. The individual secreted proteins were tested for the capacity to inhibit infection by two replication-competent recombinant vesicular stomatitis viruses (VSVs) with distinct glycoproteins utilizing different entry pathways. Fibroblast growth factor 16 (FGF16) was identified and confirmed as the most prominent novel inhibitor of both VSVs and therefore
SUBMITTER: van Asten SD
PROVIDER: S-EPMC6069191 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA